These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9331797)
1. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region. Yoshinaga M; Miyata K; Fischetti VA Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797 [No Abstract] [Full Text] [Related]
2. Intranasal immunisation of mice with a streptococcal peptide-based vaccine. Relf W; Hayman W; Russell-Jones G; Good M Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788 [No Abstract] [Full Text] [Related]
3. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210 [TBL] [Abstract][Full Text] [Related]
5. Protective immunity evoked by synthetic peptides of streptococcal M proteins. Beachey EH Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199 [No Abstract] [Full Text] [Related]
6. Immunological crossreactivity between the class I epitope of streptococcal M protein and myosin. Cunningham MW; Quinn A Adv Exp Med Biol; 1997; 418():887-92. PubMed ID: 9331792 [No Abstract] [Full Text] [Related]
7. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. Hoe NP; Kordari P; Cole R; Liu M; Palzkill T; Huang W; McLellan D; Adams GJ; Hu M; Vuopio-Varkila J; Cate TR; Pichichero ME; Edwards KM; Eskola J; Low DE; Musser JM J Infect Dis; 2000 Nov; 182(5):1425-36. PubMed ID: 11015234 [TBL] [Abstract][Full Text] [Related]
8. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. Pruksakorn S; Galbraith A; Houghten RA; Good MF J Immunol; 1992 Oct; 149(8):2729-35. PubMed ID: 1383324 [TBL] [Abstract][Full Text] [Related]
9. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479 [TBL] [Abstract][Full Text] [Related]
10. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963 [TBL] [Abstract][Full Text] [Related]
11. Estimation of type-specific anti-streptococcal M-protein antibodies with biotinylated peptides in human sera. Kühnemund O; Schumacher F; Casaretto M; Holm SE; Lütticken R APMIS; 1998 Feb; 106(2):288-92. PubMed ID: 9531961 [TBL] [Abstract][Full Text] [Related]
12. Mapping a conserved conformational epitope from the M protein of group A streptococci. Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479 [TBL] [Abstract][Full Text] [Related]
13. Horizontal transfer and mosaic-like emm gene structures in group A streptococci. Bessen DE; Hollingshead SK Dev Biol Stand; 1995; 85():169-73. PubMed ID: 8586170 [No Abstract] [Full Text] [Related]
14. The immune response to pneumococcal proteins during experimental human carriage. McCool TL; Cate TR; Moy G; Weiser JN J Exp Med; 2002 Feb; 195(3):359-65. PubMed ID: 11828011 [TBL] [Abstract][Full Text] [Related]
15. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions. Fischetti VA; Bessen DE; Schneewind O; Hruby DE Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563 [No Abstract] [Full Text] [Related]
16. Conserved and variable regions in protein Arp, the IgA receptor of Streptococcus pyogenes. Hedén LO; Lindahl G J Gen Microbiol; 1993 Sep; 139(9):2067-74. PubMed ID: 8245833 [TBL] [Abstract][Full Text] [Related]
17. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. Jones KF; Fischetti VA J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response. Schulze K; Medina E; Talay SR; Towers RJ; Chhatwal GS; Guzmán CA Infect Immun; 2001 Jan; 69(1):622-5. PubMed ID: 11119566 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells. Fluckiger U; Jones KF; Fischetti VA Infect Immun; 1998 Mar; 66(3):974-9. PubMed ID: 9488384 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer. Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]